Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-TAPENTADOL DIN 02471965

Status: Approved
Holder: APOTEX INC
Molecule: TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Health Canada record

Active ingredient(s)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 50 MG
Dosage formTablet (Immediate-Release)
RouteOral
ScheduleNARCOTICS (CDSA I)
ClassHuman
ATCN02AX06 TAPENTADOL
Original market date
Current status date17-Feb-2022
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

DINProductCompanyFormStrengthStatus
02471981APO-TAPENTADOLAPOTEX INCTablet (Immediate-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 100 MGApproved
02471973APO-TAPENTADOLAPOTEX INCTablet (Immediate-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 75 MGApproved
02415585NUCYNTA EXTENDED-RELEASEKNIGHT THERAPEUTICS INC.Tablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 100 MGMarketed
02415593NUCYNTA EXTENDED-RELEASEKNIGHT THERAPEUTICS INC.Tablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 150 MGMarketed
02415607NUCYNTA EXTENDED-RELEASEKNIGHT THERAPEUTICS INC.Tablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 200 MGMarketed
02415615NUCYNTA EXTENDED-RELEASEKNIGHT THERAPEUTICS INC.Tablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 250 MGMarketed
02415577NUCYNTA EXTENDED-RELEASEKNIGHT THERAPEUTICS INC.Tablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 50 MGMarketed
02378299NUCYNTA IRKNIGHT THERAPEUTICS INC.Tablet (Immediate-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 100 MGMarketed
02378272NUCYNTA IRKNIGHT THERAPEUTICS INC.Tablet (Immediate-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 50 MGMarketed
02378280NUCYNTA IRKNIGHT THERAPEUTICS INC.Tablet (Immediate-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 75 MGMarketed
02360373NUCYNTA CRJANSSEN INCTablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 50 MGCancelled Post Market
02360438NUCYNTA CRJANSSEN INCTablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 250 MGCancelled Post Market
02360411NUCYNTA CRJANSSEN INCTablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 200 MGCancelled Post Market
02360403NUCYNTA CRJANSSEN INCTablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 150 MGCancelled Post Market
02360381NUCYNTA CRJANSSEN INCTablet (Extended-Release)TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 100 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
276222022-02-17Abbreviated New Drug Submission (ANDS)
Request a quote for APO-TAPENTADOL

How to read a Canadian DIN record